85 related articles for article (PubMed ID: 191259)
21. Cellular immunity to mammary tumor virus in normal and tumor-bearing C3H/HeN mice.
Tagliabue A; Herberman RB; McCoy JL
Cancer Res; 1978 Aug; 38(8):2279-84. PubMed ID: 208765
[No Abstract] [Full Text] [Related]
22. Natural cytotoxicity against mouse hepatitis virus-infected target cells. I. Correlation of cytotoxicity with virus binding to leukocytes.
Holmes KV; Welsh RM; Haspel MV
J Immunol; 1986 Feb; 136(4):1446-53. PubMed ID: 3003198
[TBL] [Abstract][Full Text] [Related]
23. Detection of cell-mediated immune reactivity of breast cancer patients by the leukocyte adherence inhibition response to MCF-7 extracts.
Rudczynski AB; Dyer CA; Mortensen RF
Cancer Res; 1978 Nov; 38(11 Pt 1):3590-4. PubMed ID: 81103
[No Abstract] [Full Text] [Related]
24. A kinetic study on the deletion of thymic, peripheral, and gut-associated V beta 6+ T cells in an Mls-1b BALB/c colony infected with an exogenous mouse mammary tumor virus.
Tucek CL; Desaymard C; Papiernik M
J Immunol; 1993 Jul; 151(2):759-66. PubMed ID: 8101538
[TBL] [Abstract][Full Text] [Related]
25. Historical background and aspects of the mechanism of leukocyte adherence inhibition.
Halliday WJ
Cancer Res; 1979 Feb; 39(2 Pt 2):558-63. PubMed ID: 367582
[TBL] [Abstract][Full Text] [Related]
26. Antigenic specificity of the cytolytic T lymphocyte (CTL) response to murine sarcoma virus-induced tumors. I. Preferential reactivity of in vitro generated secondary CTL with syngeneic tumor cells.
Plata F; Jongeneel V; Cerottini JC; Brunner KT
Eur J Immunol; 1976 Nov; 6(11):823-9. PubMed ID: 187429
[TBL] [Abstract][Full Text] [Related]
27. Immunologic heterogeneity of tumor cell subpopulations from a single mouse mammary tumor.
Miller FR; Heppner GH
J Natl Cancer Inst; 1979 Dec; 63(6):1457-63. PubMed ID: 229294
[TBL] [Abstract][Full Text] [Related]
28. T cell receptor V beta repertoire in mice lacking endogenous mouse mammary tumor provirus.
Braun MY; Jouvin-Marche E; Marche PN; MacDonald HR; Acha-Orbea H
Eur J Immunol; 1995 Mar; 25(3):857-62. PubMed ID: 7705418
[TBL] [Abstract][Full Text] [Related]
29. Identification of key amino acids of the mouse mammary tumor virus superantigen involved in the specific interaction with T-cell receptor V(beta) domains.
Baribaud F; Wirth S; Maillard I; Valsesia S; Acha-Orbea H; Diggelmann H
J Virol; 2001 Aug; 75(16):7453-61. PubMed ID: 11462017
[TBL] [Abstract][Full Text] [Related]
30. Complexity of factors in sera of different mice that affect MTV-induced mammary tumor cells.
Blair PB; Lane MA; Mar P
J Immunol; 1976 Mar; 116(3):610-4. PubMed ID: 176267
[TBL] [Abstract][Full Text] [Related]
31. Dependence of initiation of an innocent bystander cytotoxicity reaction on the association of viral antigens and tumor cell membranes in mice.
Lopez DM; Lopez PF; Parks WP; Paul RD
J Natl Cancer Inst; 1986 May; 76(5):923-31. PubMed ID: 2871214
[TBL] [Abstract][Full Text] [Related]
32. Physiologic expression of two superantigens in the BDF1 mouse.
Gollob KJ; Palmer E
J Immunol; 1991 Oct; 147(8):2447-54. PubMed ID: 1655891
[TBL] [Abstract][Full Text] [Related]
33. Characteristics of mammary tumor cultures from four mouse strains infected with mammary tumor virus.
Yagi MJ
Cancer Res; 1975 Feb; 35(2):370-3. PubMed ID: 162873
[TBL] [Abstract][Full Text] [Related]
34. Rosette formation by mouse lymphocytes. III. Receptors for immunoglobulin on normal and activated T cells.
Soteriades-Vlachos C; Gyöngyössy MI; Playfair JH
Clin Exp Immunol; 1974 Oct; 18(2):187-92. PubMed ID: 4549625
[TBL] [Abstract][Full Text] [Related]
35. Nonspecific augmentation of lymph node T cells and I-E-independent selective deletion of V beta 14+ T cells by Mtv-2 in the DDD mouse.
Nakano H; Yoshimoto T; Kakiuchi T; Matsuzawa A
Eur J Immunol; 1993 Oct; 23(10):2434-9. PubMed ID: 8405042
[TBL] [Abstract][Full Text] [Related]
36. In vitro immune responses to viral and tumor antigens in murine breast cancer.
Sigel MM; Lopez DM; Ortiz-Muniz G
Cancer Res; 1976 Feb; 36(2 pt 2):748-52. PubMed ID: 1253159
[TBL] [Abstract][Full Text] [Related]
37. Studies on the induction and expression of T cell-mediated immunity. IV. Non-overlapping populations of alloimmune cytotoxic lymphocytes with specificity for tumor-associated antigens and transplantation antigens.
Kedar E; Bonavida B
J Immunol; 1975 Nov; 115(5):1301-8. PubMed ID: 51889
[TBL] [Abstract][Full Text] [Related]
38. In vitro studies of cell-mediated immunity to Moloney murine leukemia virus and Moloney leukemia-associated surface antigens.
Ng AK; Ames RS; McIntire RK; Herberman RB
Cancer Res; 1979 Dec; 39(12):4887-93. PubMed ID: 387218
[TBL] [Abstract][Full Text] [Related]
39. An adherent, radiosensitive accessory cell necessary for mouse cytolytic T lymphocyte response to viral antigen.
Fast LD; Fan DP
J Immunol; 1981 Mar; 126(3):1114-9. PubMed ID: 6970215
[TBL] [Abstract][Full Text] [Related]
40. B cell subsets in spleens of BALB/c mice: identification and isolation of MMTV-expressing and MMTV-responding subpopulations.
Lopez DM; Charyulu V; Paul RD
J Immunol; 1985 Jan; 134(1):603-7. PubMed ID: 2981095
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
